CR

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics — ensuring a higher level of healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.

At UnitedHealth Group, our mission is to help people live healthier lives. To achieve this goal, we are focused on building a modern, adaptable, innovative and inclusive system of health care services.
Our scale and potential to improve health makes us one of the most visible stewards of America’s vast health care system. Entrusted with both important resources and responsibilities, we are involved on a daily basis in decision-making that has life-changing consequences for millions of Americans.

Cliniminds is an innovative clinical research training institute providing a wide range of clinical research training solutions to the students, pharmaceutical companies, CROs and healthcare companies in India and other parts of the world.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

INC research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity.

Applications are invited from eligible candidates for admission to the following postgraduate programmes of the Institute for the session 2010-11:

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies